Vacuna Contra El Herpes Zóster Recombinante No Vivo Con Adyuvante + Recombinant Varicella Zoster Virus Glycoprotein E Antigen + Vacuna Anti Herpes Zóster + Varicella-Zoster Virus Glycoprotein E Antigen

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Vacuna Contra El Herpes Zóster Recombinante No Vivo Con Adyuvante mx-es-vacuna-contra-el-herpes-zoster-recombinante-no-vivo-con-adyuvante
Recombinant Varicella Zoster Virus Glycoprotein E Antigen recombinant-varicella-zoster-virus-glycoprotein-e-antigen
Vacuna Anti Herpes Zóster vacuna-anti-herpes-zoster
Varicella-Zoster Virus Glycoprotein E Antigen varicella-zoster-virus-glycoprotein-e-antigen

Brands with this exact combination

Brand	Composition & strength	Manufacturer
SHINGRIXAU CA CZ ES EU LV MX	liquid ×2 Varicella-Zoster Virus Glycoprotein E Antigen 0.05 mg unknown Recombinant Varicella Zoster Virus Glycoprotein E Antigen injection Vacuna Anti Herpes Zóster 0.05 mg liquid Vacuna Contra El Herpes Zóster Recombinante No Vivo Con Adyuvante	Glaxo Group Limited, Brentford

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.